Robin Swartz is COO & CBO of Voyager Therapeutics, Inc.. Currently has a direct ownership of 169,647 shares of VYGR, which is worth approximately $692,159. The most recent transaction as insider was on Feb 21, 2025, when has been sold 71,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 170K
44.99% 3M change
43.33% 12M change
Total Value Held $692,159

Robin Swartz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 21 2025
BUY
Grant, award, or other acquisition
-
71,250 Added 29.58%
169,647 Common Stock
Feb 20 2025
SELL
Open market or private sale
$16,549 $4.25 p/Share
3,894 Reduced 3.81%
98,397 Common Stock
Feb 11 2025
SELL
Open market or private sale
$30,927 $4.45 p/Share
6,950 Reduced 6.36%
102,291 Common Stock
Jan 14 2025
SELL
Open market or private sale
$15,712 $5.09 p/Share
3,087 Reduced 2.75%
109,241 Common Stock
Dec 23 2024
SELL
Open market or private sale
$36,725 $5.65 p/Share
6,500 Reduced 5.47%
112,328 Common Stock
Apr 02 2024
SELL
Open market or private sale
$13,407 $9.88 p/Share
1,357 Reduced 1.15%
117,004 Common Stock
Feb 21 2024
SELL
Open market or private sale
$29,546 $7.45 p/Share
3,966 Reduced 3.24%
118,361 Common Stock
Feb 09 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 29.01%
122,327 Common Stock
Jan 17 2024
SELL
Open market or private sale
$18,182 $7.15 p/Share
2,543 Reduced 3.4%
72,327 Common Stock
Apr 03 2023
SELL
Open market or private sale
$9,857 $7.83 p/Share
1,259 Reduced 1.73%
71,617 Common Stock
Mar 20 2023
SELL
Open market or private sale
$28,355 $7.76 p/Share
3,654 Reduced 4.77%
72,876 Common Stock
Mar 15 2023
SELL
Open market or private sale
$126,058 $8.2 p/Share
15,373 Reduced 16.73%
76,530 Common Stock
Feb 17 2023
BUY
Grant, award, or other acquisition
-
40,000 Added 30.33%
91,903 Common Stock
Jan 17 2023
SELL
Open market or private sale
$21,792 $9.96 p/Share
2,188 Reduced 4.05%
51,903 Common Stock
Apr 04 2022
SELL
Open market or private sale
$12,598 $8.25 p/Share
1,527 Reduced 2.85%
52,060 Common Stock
Mar 21 2022
SELL
Open market or private sale
$37,466 $8.49 p/Share
4,413 Reduced 7.61%
53,587 Common Stock
RS

Robin Swartz

COO & CBO
Cambridge, MA

Track Institutional and Insider Activities on VYGR

Follow Voyager Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYGR shares.

Notify only if

Insider Trading

Get notified when an Voyager Therapeutics, Inc. insider buys or sells VYGR shares.

Notify only if

News

Receive news related to Voyager Therapeutics, Inc.

Track Activities on VYGR